β-Nicotinamide Mononucleotide (NMN) to Reach USD 913.45 Million by 2032, Driven by Increasing Consumer Awareness of Anti-Aging Benefits and Advancements in Biotechnological Manufacturing | #research
β-Nicotinamide Mononucleotide (NMN) to Reach USD 913.45 Million by 2032, Driven by Increasing Consumer Awareness of Anti-Aging Benefits and Advancements in Biotechnological Manufacturing | #research